Home » Topics » Disease categories and therapies » Infection

Infection
RSS

EGS oligozymes make drug-resistant bacteria sensitive

Aug. 5, 1997

New oxazolidinones from P&U

Aug. 4, 1997

Grepafloxacin receives first approval in Germany

Aug. 4, 1997

Grepafloxacin efficacy in respiratory infections reported

Aug. 1, 1997

Korean researchers describe new cephalosporins

July 31, 1997

Antimicrobial DHFR inhibitors from Roche

July 31, 1997

New oral carbapenems with enhanced antibacterial activity

July 31, 1997

Trovafloxacin extensively covered at recent congress

July 30, 1997

Antiherpes activity of naturally occurring flavone alone and in combination with aciclovir

July 29, 1997

Pharmacopeia receives SBIR grant for development of plasmepsin inhibitors

July 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...